Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | Acsf2 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACSF2 mRNA] | CTD | PMID:31150632 | (1->4)-beta-D-glucan | multiple interactions | ISO | Acsf2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACSF2 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | ISO | Acsf2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACSF2 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | Acsf2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ACSF2 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of ACSF2 mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Acsf2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ACSF2 mRNA | CTD | PMID:21354282 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ACSF2 mRNA | CTD | PMID:21215274 | 3-chloropropane-1,2-diol | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in decreased expression of ACSF2 protein | CTD | PMID:34915118 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSF2 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of ACSF2 mRNA | CTD | PMID:27685785 | 5-aza-2'-deoxycytidine | affects expression | EXP | | 6480464 | Decitabine affects the expression of ACSF2 mRNA | CTD | PMID:23300844 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of ACSF2 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of ACSF2 mRNA | CTD | PMID:27153756 | aflatoxin B1 | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in decreased expression of ACSF2 mRNA | CTD | PMID:33354967 | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of ACSF2 mRNA and aristolochic acid I results in increased expression of ACSF2 protein | CTD | PMID:33212167 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of ACSF2 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of ACSF2 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of ACSF2 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of ACSF2 intron | CTD | PMID:30157460 | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Acsf2 (Mus musculus) | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ACSF2 mRNA] | CTD | PMID:19850644 | bis(2-ethylhexyl) phthalate | increases expression | ISO | Acsf2 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of ACSF2 mRNA | CTD | PMID:19850644 | bisphenol A | multiple interactions | ISO | Acsf2 (Rattus norvegicus) | 6480464 | [Fructose co-treated with bisphenol A] results in increased expression of ACSF2 protein | CTD | PMID:26930160 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ACSF2 protein | CTD | PMID:34186270 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of ACSF2 gene | CTD | PMID:31601247 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ACSF2 mRNA | CTD | PMID:30903817 | bisphenol A | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ACSF2 mRNA | CTD | PMID:30816183 more ... | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ACSF2 mRNA and bisphenol A results in increased expression of ACSF2 protein | CTD | PMID:27685785 and PMID:37567409 | bisphenol A | affects expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of ACSF2 mRNA | CTD | PMID:25181051 | Bisphenol B | increases expression | EXP | | 6480464 | bisphenol B results in increased expression of ACSF2 protein | CTD | PMID:34186270 | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of ACSF2 protein | CTD | PMID:34186270 | buspirone | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | Buspirone results in decreased expression of ACSF2 mRNA | CTD | PMID:24136188 | cadmium sulfate | multiple interactions | ISO | Acsf2 (Mus musculus) | 6480464 | cadmium sulfate affects the reaction [MTF1 affects the expression of ACSF2 mRNA] | CTD | PMID:16221973 | chlorpyrifos | increases expression | ISO | Acsf2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of ACSF2 mRNA | CTD | PMID:37019170 | cisplatin | affects expression | EXP | | 6480464 | Cisplatin affects the expression of ACSF2 mRNA | CTD | PMID:23300844 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of ACSF2 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ACSF2 mRNA | CTD | PMID:20106945 and PMID:25562108 | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of ACSF2 mRNA | CTD | PMID:25047013 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSF2 mRNA | CTD | PMID:28628672 | diquat | increases expression | ISO | Acsf2 (Mus musculus) | 6480464 | Diquat results in increased expression of ACSF2 mRNA | CTD | PMID:36851058 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of ACSF2 mRNA | CTD | PMID:29803840 | epoxiconazole | decreases expression | ISO | Acsf2 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of ACSF2 mRNA | CTD | PMID:35436446 | ethanol | increases expression | ISO | Acsf2 (Mus musculus) | 6480464 | Ethanol results in increased expression of ACSF2 mRNA | CTD | PMID:30319688 | fenthion | increases expression | ISO | Acsf2 (Mus musculus) | 6480464 | Fenthion results in increased expression of ACSF2 mRNA | CTD | PMID:34813904 | folic acid | multiple interactions | ISO | Acsf2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACSF2 mRNA | CTD | PMID:22206623 | fructose | multiple interactions | ISO | Acsf2 (Rattus norvegicus) | 6480464 | [Fructose co-treated with bisphenol A] results in increased expression of ACSF2 protein | CTD | PMID:26930160 | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of ACSF2 gene | CTD | PMID:31601247 | gentamycin | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ACSF2 mRNA | CTD | PMID:33387578 | glycidyl methacrylate | decreases expression | EXP | | 6480464 | glycidyl methacrylate results in decreased expression of ACSF2 protein | CTD | PMID:36641056 | glyphosate | decreases expression | ISO | Acsf2 (Mus musculus) | 6480464 | Glyphosate results in decreased expression of ACSF2 protein | CTD | PMID:37208198 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSF2 mRNA | CTD | PMID:28628672 | inulin | multiple interactions | ISO | Acsf2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACSF2 mRNA | CTD | PMID:36331819 | iron atom | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | Iron deficiency results in decreased expression of ACSF2 mRNA | CTD | PMID:16629162 | iron(0) | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | Iron deficiency results in decreased expression of ACSF2 mRNA | CTD | PMID:16629162 | isobutanol | multiple interactions | EXP | | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ACSF2 mRNA | CTD | PMID:29432896 | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of ACSF2 protein | CTD | PMID:32959892 | levofloxacin | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | Levofloxacin results in decreased expression of ACSF2 mRNA | CTD | PMID:24136188 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACSF2 mRNA | CTD | PMID:35811015 | methidathion | increases expression | ISO | Acsf2 (Mus musculus) | 6480464 | methidathion results in increased expression of ACSF2 mRNA | CTD | PMID:34813904 | methylisothiazolinone | decreases expression | EXP | | 6480464 | 2-methyl-4-isothiazolin-3-one results in decreased expression of ACSF2 mRNA | CTD | PMID:31629900 | monosodium L-glutamate | multiple interactions | ISO | Acsf2 (Mus musculus) | 6480464 | [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of ACSF2 mRNA | CTD | PMID:22078008 | nefazodone | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | nefazodone results in decreased expression of ACSF2 mRNA | CTD | PMID:24136188 | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of ACSF2 mRNA | CTD | PMID:24768652 and PMID:25583101 | nickel dichloride | affects expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | nickel chloride affects the expression of ACSF2 mRNA | CTD | PMID:22110744 | nimesulide | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | nimesulide results in decreased expression of ACSF2 mRNA | CTD | PMID:24136188 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ACSF2 mRNA | CTD | PMID:25704631 | paracetamol | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of ACSF2 mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ACSF2 mRNA | CTD | PMID:29067470 | paracetamol | decreases expression | ISO | Acsf2 (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of ACSF2 mRNA | CTD | PMID:29246445 | paracetamol | multiple interactions | ISO | Acsf2 (Mus musculus) | 6480464 | PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of ACSF2 mRNA] | CTD | PMID:29246445 | paraquat | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | Paraquat results in decreased expression of ACSF2 mRNA | CTD | PMID:32680482 | perfluorohexanesulfonic acid | increases expression | ISO | Acsf2 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of ACSF2 mRNA | CTD | PMID:37995155 | perfluorononanoic acid | decreases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of ACSF2 mRNA | CTD | PMID:32588087 | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of ACSF2 mRNA | CTD | PMID:32588087 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Acsf2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACSF2 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACSF2 mRNA | CTD | PMID:36331819 | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of ACSF2 protein | CTD | PMID:26879310 | perfluorooctanoic acid | increases expression | ISO | Acsf2 (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased expression of ACSF2 mRNA and perfluorooctanoic acid results in increased expression of ACSF2 protein | CTD | PMID:30711707 and PMID:37422089 | phenobarbital | decreases expression | ISO | Acsf2 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of ACSF2 protein | CTD | PMID:35881160 | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of ACSF2 protein | CTD | PMID:35881160 | pirinixic acid | increases expression | ISO | Acsf2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of ACSF2 mRNA | CTD | PMID:23811191 | pravastatin | increases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | Pravastatin results in increased expression of ACSF2 mRNA | CTD | PMID:27225895 | pravastatin | decreases expression | ISO | Acsf2 (Mus musculus) | 6480464 | Pravastatin results in decreased expression of ACSF2 mRNA | CTD | PMID:27225895 | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of ACSF2 mRNA | CTD | PMID:21632981 | rotenone | increases expression | ISO | Acsf2 (Mus musculus) | 6480464 | Rotenone results in increased expression of ACSF2 mRNA | CTD | PMID:35919817 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACSF2 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of ACSF2 mRNA and Silicon Dioxide results in decreased expression of ACSF2 mRNA | CTD | PMID:25895662 and PMID:28425640 | silver atom | affects expression | ISO | Acsf2 (Mus musculus) | 6480464 | Silver affects the expression of ACSF2 mRNA | CTD | PMID:27131904 | silver(0) | affects expression | ISO | Acsf2 (Mus musculus) | 6480464 | Silver affects the expression of ACSF2 mRNA | CTD | PMID:27131904 | sulforaphane | decreases expression | EXP | | 6480464 | sulforaphane results in decreased expression of ACSF2 mRNA | CTD | PMID:31838189 | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of ACSF2 mRNA | CTD | PMID:31533062 | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of ACSF2 mRNA | CTD | PMID:31758290 | tetrachloroethene | increases expression | ISO | Acsf2 (Mus musculus) | 6480464 | Tetrachloroethylene results in increased expression of ACSF2 mRNA | CTD | PMID:28973375 | tetrachloromethane | multiple interactions | ISO | Acsf2 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACSF2 mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of ACSF2 mRNA | CTD | PMID:31150632 | thioacetamide | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of ACSF2 mRNA | CTD | PMID:34492290 | titanium dioxide | decreases expression | ISO | Acsf2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of ACSF2 mRNA | CTD | PMID:23409001 | titanium dioxide | increases expression | ISO | Acsf2 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of ACSF2 mRNA | CTD | PMID:29264374 | trichloroethene | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of ACSF2 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of ACSF2 mRNA | CTD | PMID:24935251 | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of ACSF2 mRNA | CTD | PMID:30510588 | tris(2-butoxyethyl) phosphate | affects expression | EXP | | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of ACSF2 mRNA | CTD | PMID:29024780 | trovafloxacin | decreases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | trovafloxacin results in decreased expression of ACSF2 mRNA | CTD | PMID:24136188 | tungsten | decreases expression | ISO | Acsf2 (Mus musculus) | 6480464 | Tungsten results in decreased expression of ACSF2 mRNA | CTD | PMID:30912803 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of ACSF2 mRNA | CTD | PMID:28818685 | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of ACSF2 gene | CTD | PMID:29154799 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSF2 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of ACSF2 mRNA | CTD | PMID:23179753 and PMID:26272509 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ACSF2 mRNA | CTD | PMID:25979313 | vorinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSF2 mRNA | CTD | PMID:27188386 | zaragozic acid A | increases expression | ISO | Acsf2 (Rattus norvegicus) | 6480464 | squalestatin 1 results in increased expression of ACSF2 mRNA | CTD | PMID:27225895 | zaragozic acid A | affects expression | ISO | Acsf2 (Mus musculus) | 6480464 | squalestatin 1 affects the expression of ACSF2 mRNA | CTD | PMID:27225895 | zearalenone | increases expression | ISO | Acsf2 (Mus musculus) | 6480464 | Zearalenone results in increased expression of ACSF2 protein | CTD | PMID:25058043 | |